Beam Therapeutics, Inc. (BEAM)
29.43
+0.11
(+0.38%)
USD |
NASDAQ |
Aug 31, 16:00
29.49
+0.06
(+0.20%)
After-Hours: 20:00
Beam Therapeutics Cash from Operations (Annual) : -345.10M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -345.10M |
| December 31, 2024 | -347.25M |
| December 31, 2023 | -149.20M |
| December 31, 2022 | 22.53M |
| December 31, 2021 | -66.27M |
| Date | Value |
|---|---|
| December 31, 2020 | -95.74M |
| December 31, 2019 | -72.00M |
| December 31, 2018 | -20.30M |
| December 31, 2017 | -2.707M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Twist Bioscience Corp. | -47.63M |
| Prime Medicine, Inc. | -162.56M |
| Intellia Therapeutics, Inc. | -394.74M |
| Sana Biotechnology, Inc. | -143.83M |
| Revolution Medicines, Inc. | -897.74M |